Impact of Pre-Transplant Rituximab on Efficacy of Revaccination of Lymphoma Patients after Autologous Hematopoietic Stem Cell Transplantation
Conclusions: Response to reimmunization with inactivated vaccines in lymphoma patients after AHCT is similar to previously reported populations, but prior rituximab exposure appears to impact response.DisclosuresMatasar: Seattle Genetics: Honoraria. Moskowitz: Merck & Co: Consultancy, Research Funding; Genentech: Consultancy, Research Funding; Pharmacyclics: Research Funding; Seattle Genetics: Consultancy, Research Funding; Celgene: Consultancy. Sauter: Juno Therapeutics: Consultancy, Research Funding; Sanofi-Genzyme: Consultancy, Research Funding; Spectrum Pharmaceuticals: Consultancy; Novartis: Consultancy; Precision Biosciences: Consultancy; Kite: Consultancy. Shah: Amgen: Research Funding; Janssen: Research Funding. Perales: Abbvie: Other: Personal fees; Incyte: Membership on an entity's Board of Directors or advisory committees, Other: Personal fees and Clinical trial support; Takeda: Other: Personal fees; Merck: Other: Personal fees; Novartis: Other: Personal fees.
Source: Blood - Category: Hematology Authors: Preston, E. V., Palazzo, M. A., Seier, K., Devlin, S. M., Giralt, S., Scordo, M., Dahi, P. B., Matasar, M. J., Moskowitz, C. H., Sauter, C. S., Shah, G. L., Perales, M.-A. Tags: 723. Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence: Poster III Source Type: research
More News: Clinical Trials | Databases & Libraries | Diphtheria | Genetics | Haemophilus Influenzae (Hib) | Hepatitis | Hepatitis A | Hepatitis B | Hepatitis Vaccine | Hodgkin's Disease | Influenza Vaccine | Lymphoma | Meningitis Vaccine | Merck | Non-Hodgkin's Lymphoma | Pneomococcal Vaccine | Polio | Polio Vaccine | Rituxan | Statistics | Stem Cell Therapy | Stem Cells | Tetanus | Tetanus Diptheria Pertussis Vaccine Tdap,Dtap,Dpt | Tetanus Vaccine | Transplants | Vaccines | Whooping Cough (Pertussis) Vaccine